Written by Cassian Vance
The global financial markets are holding their collective breath. On May 14 and 15, 2026, U.S. President Donald Trump will meet with Chinese President Xi Jinping in Beijing [1]. This marks the first visit by an American leader to the Chinese capital in nearly a decade, and it stands as the most consequential geopolitical event of the second quarter.
The stakes could not be higher. The S&P 500 and Nasdaq Composite just closed their sixth consecutive week of gains, both reaching new all-time highs on May 8 [2]. Yet, this historic bull run is vulnerable to the shifting winds of international trade. With Trump’s domestic disapproval rating at a record high of 62% [3], the administration is desperate for an economic victory ahead of the November midterm elections. Conversely, China’s merchandise exports to the U.S. fell 10.2% year-over-year in the first four months of 2026 [1], making Beijing equally eager to secure a trade truce.
The summit’s agenda is dense, encompassing everything from agricultural purchases and semiconductor export controls to the ongoing war in Iran and tensions over Taiwan [1]. For investors, the challenge is not predicting the diplomatic nuances, but identifying the specific equities positioned to surge—or plummet—based on the summit’s outcome.
The Boeing Mega-Deal
The most tangible, immediate catalyst expected from the summit involves The Boeing Company (BA). According to multiple reports, Boeing CEO Kelly Ortberg is joining the presidential delegation to Beijing [4]. This inclusion is a massive signal to the market.
Since the first round of trade tensions during Trump’s initial term, China has largely frozen Boeing orders, frequently favoring European rival Airbus to fulfill its vast aviation needs [4]. However, industry sources indicate that the U.S. and China have been in prolonged negotiations for a monumental package that could include up to 500 Boeing 737 MAX aircraft and dozens of widebody jets [5].
A deal of this magnitude would be transformative. It would instantly inject massive volume into Boeing’s production pipeline, helping the company reclaim global market share and bolstering its already record $695 billion backlog [4]. Boeing is already in the midst of a fundamental recovery, projecting up to $3 billion in free cash flow for 2026 and ramping up 787 Dreamliner production to 10 units per month [4].
Thesis on BA: BUY
Boeing shares have already rallied more than 20% from their late-March lows, closing the week around $237 [4] [6]. However, the stock still has significant runway. The consensus Wall Street rating remains a “Strong Buy,” with a mean price target of $270 [4]. If the 500-jet mega-order is officially signed in Beijing, it will serve as the ultimate validation of Boeing’s turnaround story. Furthermore, Boeing’s defense unit stands to benefit disproportionately from the Trump administration’s proposed $1.5 trillion defense budget [4]. The risk-reward profile is highly asymmetric to the upside.
The Semiconductor Chess Match
While Boeing represents the most direct trade catalyst, the semiconductor sector remains the most complex battleground. Beijing’s primary objective at the summit is to secure an easing of U.S. curbs on advanced semiconductors and halt the tightening of export controls [1]. In exchange, Washington is demanding that China lift its own controls on rare earths and critical minerals [1].
This dynamic creates a precarious situation for U.S. chipmakers. Companies like NVIDIA (NVDA) and Advanced Micro Devices (AMD) have effectively been locked out of their most lucrative foreign market for high-end AI accelerators. If the Trump administration agrees to even a partial rollback of these export controls as part of a broader trade truce, it would instantly expand the total addressable market for American AI hardware.
However, the U.S. is highly unlikely to surrender its technological leverage easily. The AI arms race is viewed as a critical national security priority.
Thesis on NVDA: HOLD
NVIDIA is currently trading near $215, up roughly 15.3% year-to-date [7]. While a relaxation of export controls would undoubtedly trigger a massive rally, investors should not front-run the summit on this specific issue. The technological divide between the U.S. and China is structural and deep-rooted. A breakthrough on agricultural purchases or commercial aviation is far more likely than a concession on advanced AI silicon. Investors should hold existing positions in NVIDIA and wait for the company’s May 20 earnings report, which will provide a much clearer picture of global demand exclusive of the Chinese market.
The Alibaba Revival
The broader implications of a successful summit—specifically, an extension of the current trade truce—would be profoundly bullish for Chinese equities listed on U.S. exchanges. The specter of renewed tariffs, which Treasury Secretary Scott Bessent warned could go into effect in July if negotiations fail [1], has kept a heavy lid on Chinese tech valuations.
Alibaba Group Holding (BABA) is the prime candidate for a relief rally. The e-commerce giant is scheduled to report its fiscal fourth-quarter 2026 earnings on May 13 [8], precisely as the summit kicks off. The stock has been a chronic underperformer, down 3% year-to-date despite a 12% rally in April [9].
Thesis on BABA: BUY
Alibaba is trading at deeply distressed valuation multiples relative to its American peers. While the company’s profitability has faced recent headwinds [10], the underlying business remains a cash-generating juggernaut. If the Trump-Xi summit produces a 90-day extension of the trade truce [1], the geopolitical risk premium currently suffocating Alibaba shares will rapidly evaporate. Options markets are already pricing in a larger-than-usual move around the May 13 earnings report [11]. The confluence of a trade truce and an earnings beat could trigger a violent short squeeze, making Alibaba a compelling, albeit aggressive, tactical buy.
References
[1] Yahoo Finance. “Trump-Xi summit: Here’s everything you need to know.” https://uk.finance.yahoo.com/news/trump-xi-summit-everything-know-040209653.html
[2] The Motley Fool. “Stock Market Today, May 8: Nasdaq Gains 1.7% on AI Demand and Strong Jobs Data.” https://www.fool.com/coverage/stock-market-today/2026/05/08/stock-market-today-may-8-nasdaq-gains-1-7-on-ai-demand-and-strong-jobs-data/
[3] The Guardian. “Tehran, Taiwan, trade … what are the hazards facing Donald Trump and Xi Jinping?” https://www.theguardian.com/news/ng-interactive/2026/may/10/tehran-taiwan-trade-donald-trump-xi-jinping-us-china-summit
[4] Barchart. “BA Stock Alert: What to Expect as Boeing CEO Joins Trump on China Trip.” https://www.barchart.com/story/news/1780098/ba-stock-alert-what-to-expect-as-boeing-ceo-joins-trump-on-china-trip
[5] Reuters. “Trump administration plans to invite CEOs of Nvidia, Apple, Exxon to Trump’s China trip.” https://www.reuters.com/business/aerospace-defense/trump-administration-plans-invite-ceos-nvidia-apple-exxon-trumps-china-trip-2026-05-07/
[6] Morningstar. “BA Stock – Boeing Stock Price Quote.” https://www.morningstar.com/stocks/xnys/ba/quote
[7] Yahoo Finance. “Goldman Sachs resets Nvidia stock forecast ahead of earnings.” https://sg.finance.yahoo.com/news/goldman-sachs-resets-nvidia-stock-164700393.html
[8] MarketBeat. “Alibaba Group Q4 2026 Earnings Report.” https://www.marketbeat.com/earnings/reports/2026-5-13-alibaba-group-holding-limited-stock/
[9] Investor’s Business Daily. “Stock Market Week Ahead: Dow Jones Breakout Watch.” https://www.investors.com/research/investing-action-plan/stock-market-week-ahead-dow-jones-breakout-watch/
[10] Seeking Alpha. “Alibaba Making All The Right Moves, But It’s Not On Sale Yet.” https://seekingalpha.com/article/4901872-alibaba-making-all-right-moves-but-not-on-sale-yet
[11] Smartkarma. “Alibaba (BABA US): Options Price a Big Earnings Move on 13 May.” https://www.smartkarma.com/insights/alibaba-baba-us-options-price-a-big-earnings-move-on-13-may
────────────────────────────────────────────────────────────
Disclaimer: This article is for informational purposes only and does not constitute investment advice. The opinions expressed are those of the author and do not reflect the views of Equities Orbis or its affiliates. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
